{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:15:50Z","timestamp":1783296950557,"version":"3.54.6"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pulmonary arterial hypertension (PAH) often leads to right heart failure and death. While pharmacological therapies offer symptomatic relief and functional improvement, many patients remain refractory or progress despite optimal treatment. This review explores emerging interventional strategies besides pharmacotherapy. Techniques such as pulmonary artery denervation (PADN), balloon atrial septostomy (BAS), renal denervation, transcatheter Potts shunt, right ventricular assist devices, catheter-based cell therapies and implantable hemodynamic monitoring devices are evaluated based on safety, efficacy, and long-term outcomes. Notably, PADN has demonstrated encouraging results across multiple trials, with improvements in exercise capacity, hemodynamic parameters, and clinical status. BAS remains a palliative bridge to transplantation in severe cases, with newer modifications aiming to overcome spontaneous closure. Renal denervation and transcatheter Potts shunts show promise but require further validation. Catheter-based cell therapies show promising results and could perhaps be used as an alternative in the future. Moreover, mechanical support devices like ECMO and pressure monitors such as CardioMEMS offer adjunctive benefits in advanced disease. Right ventricular assist devices could in circumstances be used as bridge to transplant or bridge to recovery. This review illustrates the need for robust randomized controlled trials in PAH.<\/jats:p>","DOI":"10.1038\/s41440-026-02660-2","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T07:00:58Z","timestamp":1779174058000},"page":"2181-2189","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interventional strategies for pulmonary arterial hypertension: Current perspectives and future directions"],"prefix":"10.1038","volume":"49","author":[{"given":"Konstantinos","family":"Platanias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stergios","family":"Soulaidopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios","family":"Sagris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Makris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Touriki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Giannakodimos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costas","family":"Thomopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Tsioufis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"2660_CR1","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.repc.2024.03.004","volume":"43","author":"M Azaredo Raposo","year":"2024","unstructured":"Azaredo Raposo M, In\u00e1cio Cazeiro D, Guimar\u00e3es T, Lousada N, Freitas C, Brito J, et al. Pulmonary arterial hypertension: navigating the pathways of progress in diagnosis, treatment, and patient care. Rev Port Cardiol. 2024;43:699\u2013719.","journal-title":"Rev Port Cardiol"},{"key":"2660_CR2","doi-asserted-by":"crossref","unstructured":"Fisher NDL, Kirtane AJ. Renal denervation for hypertension. Nat Rev Cardiol 2025; in press.","DOI":"10.1038\/s41569-024-01104-z"},{"key":"2660_CR3","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1055\/s-0043-1772752","volume":"44","author":"MM Hoeper","year":"2023","unstructured":"Hoeper MM. Extracorporeal life support in pulmonary hypertension: practical aspects. Semin Respir Crit Care Med. 2023;44:771\u20136.","journal-title":"Semin Respir Crit Care Med"},{"key":"2660_CR4","doi-asserted-by":"crossref","unstructured":"Kovacs G, Bartolome S, Denton CP, Gatzoulis MA, Gu S, Khanna D et al. Definition, classification and diagnosis of pulmonary hypertension. Eur Respir J 2024;64:1\u201316.","DOI":"10.1183\/13993003.01324-2024"},{"key":"2660_CR5","doi-asserted-by":"publisher","first-page":"829","DOI":"10.21037\/atm-20-2171","volume":"8","author":"ASK Wong","year":"2020","unstructured":"Wong ASK, Sin SWC. Short-term mechanical circulatory support (intra-aortic balloon pump, Impella, extracorporeal membrane oxygenation, TandemHeart): a review. Ann Transl Med. 2020;8:829.","journal-title":"Ann Transl Med"},{"key":"2660_CR6","first-page":"183","volume":"110","author":"K Latimer","year":"2024","unstructured":"Latimer K, Layne M, Payne M. Pulmonary hypertension. Am Fam Physician. 2024;110:183\u201391.","journal-title":"Am Fam Physician"},{"key":"2660_CR7","volume":"121","author":"EPB Ojopi","year":"2024","unstructured":"Ojopi EPB, Tonon CR, Okoshi K, Okoshi MP. Pulmonary arterial hypertension and cardioprotective interventions. Arq Bras Cardiol. 2024;121:e20240445.","journal-title":"Arq Bras Cardiol"},{"key":"2660_CR8","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1111\/imj.16515","volume":"54","author":"JD Prasad","year":"2024","unstructured":"Prasad JD, Williams TJ, Whitford HM. Pulmonary arterial hypertension: updates and perspective with newer therapies. Intern Med J. 2024;54:1944\u201351.","journal-title":"Intern Med J"},{"key":"2660_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2025.133078","volume":"427","author":"MR Abouzid","year":"2025","unstructured":"Abouzid MR, Kamel I, Twayana AR, Shrestha S, Saleh A, Elshafei S, et al. Pulmonary artery denervation in pulmonary hypertension: a comprehensive meta-analysis. Int J Cardiol. 2025;427:133078.","journal-title":"Int J Cardiol"},{"key":"2660_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2025.133225","volume":"431","author":"M Fukumitsu","year":"2025","unstructured":"Fukumitsu M, Saku K. Pulmonary artery denervation: from hope to clinical reality. Int J Cardiol. 2025;431:133225.","journal-title":"Int J Cardiol"},{"key":"2660_CR11","first-page":"E446","volume":"97","author":"S Gurevich","year":"2021","unstructured":"Gurevich S, Prins KW. The evolving role of interventional cardiology in the treatment of pulmonary hypertension. Catheter Cardiovasc Interv. 2021;97:E446\u201353.","journal-title":"Catheter Cardiovasc Interv"},{"key":"2660_CR12","doi-asserted-by":"crossref","unstructured":"McMaster MW, Shah A, Hassid Y, Garg J, Frishman WH, Aronow WS Pulmonary artery denervation: an emerging treatment for pulmonary hypertension. Cardiol Rev 2024; in press.","DOI":"10.1097\/CRD.0000000000000800"},{"key":"2660_CR13","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.jacc.2013.05.075","volume":"62","author":"SL Chen","year":"2013","unstructured":"Chen SL, Zhang FF, Xu J, Xie DJ, Zhou L, Nguyen T, et al. Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study. J Am Coll Cardiol. 2013;62:1092\u2013100.","journal-title":"J Am Coll Cardiol"},{"key":"2660_CR14","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jcin.2018.09.021","volume":"12","author":"H Zhang","year":"2019","unstructured":"Zhang H, Zhang J, Chen M, Xie DJ, Kan J, Yu W, et al. Pulmonary artery denervation significantly increases 6-min walk distance for patients with combined pre- and post-capillary pulmonary hypertension associated with left heart failure: the PADN-5 study. JACC Cardiovasc Interv. 2019;12:274\u201384.","journal-title":"JACC Cardiovasc Interv"},{"key":"2660_CR15","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.jchf.2023.05.016","volume":"11","author":"H Zhang","year":"2023","unstructured":"Zhang H, Kan J, Zhang J, Xie D, Li X, Zhou W, et al. 3-year outcome in patients with combined precapillary and postcapillary pulmonary hypertension: results from PADN-5 trial. JACC Heart Fail. 2023;11:1135\u201346.","journal-title":"JACC Heart Fail"},{"key":"2660_CR16","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jcin.2019.12.027","volume":"13","author":"AMK Rothman","year":"2020","unstructured":"Rothman AMK, Vachiery JL, Howard LS, Mikhail GW, Lang IM, Jonas M, et al. Intravascular Ultrasound Pulmonary Artery Denervation to Treat Pulmonary Arterial Hypertension (TROPHY1): Multicenter, Early Feasibility Study. JACC Cardiovasc Interv. 2020;13:989\u201399.","journal-title":"JACC Cardiovasc Interv"},{"key":"2660_CR17","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1016\/j.jcin.2022.09.013","volume":"15","author":"H Zhang","year":"2022","unstructured":"Zhang H, Wei Y, Zhang C, Yang Z, Kan J, Gu H, et al. Pulmonary artery denervation for pulmonary arterial hypertension: a sham-controlled randomized PADN-CFDA trial. JACC Cardiovasc Interv. 2022;15:2412\u201323.","journal-title":"JACC Cardiovasc Interv"},{"key":"2660_CR18","doi-asserted-by":"publisher","first-page":"684","DOI":"10.4244\/EIJ-D-23-00349","volume":"19","author":"J Kan","year":"2023","unstructured":"Kan J, Zhang H, Xie D, Wei Y, Zhang J, Zhang C, et al. A sham-controlled randomised trial of pulmonary artery denervation for group 1 pulmonary arterial hypertension: one-year outcomes of the PADN-CFDA trial. EuroIntervention. 2023;19:684\u201394.","journal-title":"EuroIntervention"},{"key":"2660_CR19","doi-asserted-by":"publisher","DOI":"10.2174\/0118743064344024250203101417","volume":"19","author":"V Paudyal","year":"2025","unstructured":"Paudyal V, Thapa R, Basnet S, Sharma M, Surani S, Varon J. Updates on pulmonary hypertension. Open Respir Med J. 2025;19:e18743064344024.","journal-title":"Open Respir Med J"},{"key":"2660_CR20","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1136\/heartjnl-2022-321212","volume":"108","author":"C Yan","year":"2022","unstructured":"Yan C, Wan L, Li H, Wang C, Guo T, Niu H, et al. First in-human modified atrial septostomy combining radiofrequency ablation and balloon dilation. Heart. 2022;108:1690\u20138.","journal-title":"Heart"},{"key":"2660_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.chest.2019.03.003","volume":"156","author":"MS Khan","year":"2019","unstructured":"Khan MS, Memon MM, Amin E, Yamani N, Khan SU, Figueredo VM, et al. Use of balloon atrial septostomy in patients with advanced pulmonary arterial hypertension: a systematic review and meta-analysis. Chest. 2019;156:53\u201363.","journal-title":"Chest"},{"key":"2660_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2025.133129","volume":"428","author":"W Jiang","year":"2025","unstructured":"Jiang W, Wu Z, Huang C, Lu T, Yuan H, Liu Y, et al. Reverse Potts shunt in severe pulmonary hypertension: a 20-year retrospective review. Int J Cardiol. 2025;428:133129.","journal-title":"Int J Cardiol"},{"key":"2660_CR23","doi-asserted-by":"publisher","unstructured":"Michel S, Pattathu J, H\u00f6rer J, Kari FA. Reversed valved Potts shunt for refractory primary pulmonary arterial hypertension. Multimed Man Cardiothorac Surg 2025:1\u201323. https:\/\/doi.org\/10.1510\/mmcts.2024.120.","DOI":"10.1510\/mmcts.2024.120"},{"key":"2660_CR24","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.jtcvs.2023.11.045","volume":"168","author":"E Valdeolmillos","year":"2024","unstructured":"Valdeolmillos E, Le Pavec J, Audi\u00e9 M, Savale L, Jais X, Montani D, et al. Thirty years of surgical management of pediatric pulmonary hypertension: mid-term outcomes following reverse Potts shunt and transplantation. J Thorac Cardiovasc Surg. 2024;168:943\u201354.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2660_CR25","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.healun.2013.02.003","volume":"32","author":"HO Ventura","year":"2013","unstructured":"Ventura HO. Transcatheter Potts shunt: an innovative idea. J Heart Lung Transplant. 2013;32:388\u20139.","journal-title":"J Heart Lung Transplant"},{"key":"2660_CR26","first-page":"1188","volume":"33","author":"Y Boudjemline","year":"2017","unstructured":"Boudjemline Y, Sizarov A, Malekzadeh-Milani S, Mirabile C, Lenoir M, Khraiche D, et al. Safety and feasibility of the transcatheter approach to create a reverse Potts shunt in children with idiopathic pulmonary arterial hypertension. Can J Cardiol. 2017;33:1188\u201396.","journal-title":"Can J Cardiol"},{"key":"2660_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.1028304","volume":"9","author":"RN Haddad","year":"2022","unstructured":"Haddad RN, Levy M, Szezepanski I, Malekzadeh-Milani S, Bonnet D. Long-term outcomes of transcatheter Potts shunt in children with suprasystemic pulmonary arterial hypertension. Front Cardiovasc Med. 2022;9:1028304.","journal-title":"Front Cardiovasc Med"},{"key":"2660_CR28","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1177\/0267659120954169","volume":"36","author":"C Mirabile","year":"2021","unstructured":"Mirabile C, Malekzadeh-Milani S, Bojan M, Raisky O, Gaudin R, Bonnet D, et al. A case series of transcatheter Potts shunt creation in a pediatric population affected with refractory pulmonary artery hypertension: focus on the role of ECMO. Perfusion. 2021;36:415\u201320.","journal-title":"Perfusion"},{"key":"2660_CR29","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1038\/s41440-024-01776-7","volume":"47","author":"K Shinohara","year":"2024","unstructured":"Shinohara K. Renal denervation: a key approach to hypertension and cardiovascular disease. Hypertens Res. 2024;47:2671\u20137.","journal-title":"Hypertens Res"},{"key":"2660_CR30","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.recesp.2014.11.025","volume":"68","author":"Z Qingyan","year":"2015","unstructured":"Qingyan Z, Xuejun J, Yanhong T, Zixuan D, Xiaozhan W, Xule W, et al. Beneficial effects of renal denervation on pulmonary vascular remodeling in experimental pulmonary artery hypertension. Rev Esp Cardiol. 2015;68:562\u201370.","journal-title":"Rev Esp Cardiol"},{"key":"2660_CR31","doi-asserted-by":"publisher","first-page":"46846","DOI":"10.18632\/oncotarget.15154","volume":"8","author":"Q Liu","year":"2017","unstructured":"Liu Q, Song J, Lu D, Geng J, Jiang Z, Wang K, et al. Effects of renal denervation on monocrotaline induced pulmonary remodeling. Oncotarget. 2017;8:46846\u201355.","journal-title":"Oncotarget"},{"key":"2660_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/4248111","volume":"2021","author":"AD Vakhrushev","year":"2021","unstructured":"Vakhrushev AD, Condori Leonardo HI, Goncharova NS, Korobchenko LE, Mitrofanova LB, Andreeva EM, et al. Pulmonary and systemic hemodynamics following multielectrode radiofrequency catheter renal denervation in acutely induced pulmonary arterial hypertension in swine. Biomed Res Int. 2021;2021:4248111.","journal-title":"Biomed Res Int"},{"key":"2660_CR33","doi-asserted-by":"publisher","first-page":"2003957","DOI":"10.1183\/13993003.03957-2020","volume":"58","author":"CE Evans","year":"2021","unstructured":"Evans CE, Cober ND, Dai Z, Stewart DJ, Zhao YY. Endothelial cells in the pathogenesis of pulmonary arterial hypertension. Eur Respir J. 2021;58:2003957.","journal-title":"Eur Respir J"},{"key":"2660_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104900","volume":"100","author":"MI Lewis","year":"2024","unstructured":"Lewis MI, Shapiro S, Oudiz RJ, Nakamura M, Geft D, Matusov Y, et al. The ALPHA phase 1 study: pulmonary arterial hypertension treated with Cardiosphere-derived allogeneic stem cells. EBioMedicine. 2024;100:104900.","journal-title":"EBioMedicine"},{"key":"2660_CR35","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.chest.2019.06.010","volume":"156","author":"RL Benza","year":"2019","unstructured":"Benza RL, Doyle M, Lasorda D, Parikh KS, Correa-Jaque P, Badie N, et al. Monitoring pulmonary arterial hypertension using an implantable hemodynamic sensor. Chest. 2019;156:1176\u201386.","journal-title":"Chest"},{"key":"2660_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cardfail.2010.08.002","volume":"17","author":"PB Adamson","year":"2011","unstructured":"Adamson PB, Abraham WT, Aaron M, Aranda JM, Bourge RC, Smith A, et al. CHAMPION trial rationale and design: the long-term safety and clinical efficacy of a wireless pulmonary artery pressure monitoring system. J Card Fail. 2011;17:3\u201310.","journal-title":"J Card Fail"},{"key":"2660_CR37","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1080\/17434440.2023.2228683","volume":"20","author":"R Vyas","year":"2023","unstructured":"Vyas R, Patel M, Khouri SJ, Moukarbel GV. A profile on the CardioMEMS HF system in the management of patients with early stages of heart failure: an update. Expert Rev Med Devices. 2023;20:621\u201331.","journal-title":"Expert Rev Med Devices"},{"key":"2660_CR38","volume":"3","author":"C Labrandero","year":"2024","unstructured":"Labrandero C, Deiros L, Abelleira C, Arreo V, Balbacid EJ, Guti\u00e9rrez-Larraya F. Hemodynamic monitoring of pediatric patients with heart failure and pulmonary hypertension using CardioMEMS. J Soc Cardiovasc Angiogr Interv. 2024;3:101933.","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"2660_CR39","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/ejcts\/ezx047","volume":"52","author":"J Salman","year":"2017","unstructured":"Salman J, Ius F, Sommer W, Siemeni T, Kuehn C, Avsar M, et al. Mid-term results of bilateral lung transplant with postoperatively extended intraoperative extracorporeal membrane oxygenation for severe pulmonary hypertension. Eur J Cardiothorac Surg. 2017;52:163\u201370.","journal-title":"Eur J Cardiothorac Surg"},{"key":"2660_CR40","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/ejcts\/ezx212","volume":"53","author":"B Moser","year":"2018","unstructured":"Moser B, Jaksch P, Taghavi S, Murak\u00f6zy G, Lang G, Hager H, et al. Lung transplantation for idiopathic pulmonary arterial hypertension on intraoperative and postoperatively prolonged extracorporeal membrane oxygenation provides optimally controlled reperfusion and excellent outcome. Eur J Cardiothorac Surg. 2018;53:178\u201385.","journal-title":"Eur J Cardiothorac Surg"},{"key":"2660_CR41","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/j.transproceed.2020.02.113","volume":"52","author":"T St\u0105cel","year":"2020","unstructured":"St\u0105cel T, Anto\u0144czyk R, Latos M, N\u0119cki M, Przyby\u0142owski P, Zembala M, et al. Extracorporeal membrane oxygenation as a postoperative left ventricle conditioning tool after lung transplantation in patients with primary pulmonary artery hypertension: first Polish experience. Transpl Proc. 2020;52:2113\u20137.","journal-title":"Transpl Proc"},{"key":"2660_CR42","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.transproceed.2024.02.017","volume":"56","author":"T St\u0105cel","year":"2024","unstructured":"St\u0105cel T, Kegler K, M\u0119drala A, Sybila P, Ochman M, N\u0119cki M, et al. Lung transplantation in patients with pulmonary hypertension with extracorporeal membrane oxygenation support: 5-year experience. Transpl Proc. 2024;56:898\u2013903.","journal-title":"Transpl Proc"},{"key":"2660_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1283065","volume":"11","author":"B Pequignot","year":"2024","unstructured":"Pequignot B, Chaouat A, Chabot F, Levy B, Valentin S. Case report: extracorporeal life support as a successful bridge to recovery in an incident case of pulmonary arterial hypertension. Front Med. 2024;11:1283065.","journal-title":"Front Med"},{"key":"2660_CR44","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.pcad.2012.07.008","volume":"55","author":"L Punnoose","year":"2012","unstructured":"Punnoose L, Burkhoff D, Rich S, Horn EM. Right ventricular assist device in end-stage pulmonary arterial hypertension: insights from a computational model of the cardiovascular system. Prog Cardiovasc Dis. 2012;55:234\u201343.","journal-title":"Prog Cardiovasc Dis"},{"key":"2660_CR45","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.mechrescom.2019.04.008","volume":"97","author":"SM Shavik","year":"2019","unstructured":"Shavik SM, Zhong L, Zhao X, Lee LC. In-silico assessment of the effects of right ventricular assist device on pulmonary arterial hypertension using an image based biventricular modeling framework. Mech Res Commun. 2019;97:101\u201311.","journal-title":"Mech Res Commun"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02660-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02660-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02660-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:04:47Z","timestamp":1783296287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02660-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2660"],"URL":"https:\/\/doi.org\/10.1038\/s41440-026-02660-2","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"26 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}